Bugs4Urate - Precision Nutrition Strategies for Investigating Probiotic, Diet, Glycan, and Microbiome Factors in Hyperuricemia and Gout Prevention

This project aims to develop a precision nutrition approach using a novel probiotic to lower urate levels and prevent gout by analyzing gut microbiome interactions and individual responses.

Subsidie
€ 3.765.840
2024

Projectdetails

Introduction

Gout is a prevalent lifestyle-related non-communicable disease (NCD) on the rise in Europe, causing low quality of life, yet with inefficient means for treatment. An effective approach to manage hyperuricemia, the precursor to gout, would significantly enhance health outcomes and have a profound impact.

Project Overview

Using a novel probiotic food ingredient with urate-lowering properties, we target the gut microbiome to eradicate urate in a precision nutrition framework. This framework contextualizes factors of the habitual diet, host gut microbiome, and host genetics to establish a responder/non-responder instrument.

Methodology

We will employ a diverse array of methods, including:

  1. Machine learning applied to existing clinical and omics observational data.
  2. Ex-vivo dietary fiber and probiotic refinement.
  3. Two human intervention studies.

Mode-of-Action Study

In healthy adults (n = 8), we will conduct a mode-of-action study utilizing a crossover design, including small intestine biopsy sampling to assess local activity.

Proof-of-Concept Study

In hyperuricemic participants (n = 99), we will conduct a three-armed, placebo-controlled proof-of-concept study to assess the efficacy of probiotic treatment (with and without fiber), combined with a responder/non-responder instrument.

Comprehensive Analyses

Using comprehensive longitudinal analyses in metabolomics, microbiome, transcriptomics, and glycomics, we aim to uncover the molecular dynamics between:

  • Dietary patterns
  • Established bacterial enzymatic processes
  • Urate breakdown
  • Resultant shifts in inflammation within the gut and throughout the circulatory system

Innovation in Glycomics Technology

By innovating the glycomics technology to accommodate alternative bio-specimens, we hope to enable straightforward home sampling and initiate early diagnostic procedures for broad population oversight.

Conclusion

Through the application of multi-omics, we aim to develop an effective responder/non-responder instrument for probiotic intervention focused on serum urate reduction, inflammation control, and gout prevention.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.765.840
Totale projectbegroting€ 3.765.840

Tijdlijn

Startdatum1-9-2024
Einddatum31-8-2027
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • KOBENHAVNS UNIVERSITETpenvoerder
  • OREBRO UNIVERSITY
  • ACADEMISCH ZIEKENHUIS LEIDEN
  • NEOBIOSYS
  • BEO THERAPEUTICS APS

Land(en)

DenmarkSwedenNetherlandsFrance

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH

iNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment.

€ 3.194.343
EIC Pathfinder

Precision Nutrition to optimize immune response for metabolic health

NUTRIMMUNE investigates the impact of precision nutrition on immune responses in obesity-related NCDs, aiming to establish dietary recommendations through multi-omics analysis and intervention studies.

€ 4.318.432
EIC Pathfinder

Understanding the potential of modulating Host-Microbiome-Glycan interactions (“the triangle of sweetness”) to tackle non-communicable diseases

The project aims to identify novel glycosyltransferases and HMOs, analyze their gut interactions, and validate an HMO for inflammation relief, enhancing glycobiology research and therapeutic applications.

€ 3.920.718
EIC Pathfinder

Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sources

FIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS.

€ 3.449.447
EIC Pathfinder

Glucose variability patterns for precision nutrition in diabetes

The GLUCOTYPES project aims to identify early glycaemic patterns and their dietary influences using advanced technologies to develop precision nutrition strategies for Type 2 diabetes prevention and management.

€ 3.988.206

Vergelijkbare projecten uit andere regelingen

ERC Proof of...

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

€ 150.000
ERC Consolid...

Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition

The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.

€ 2.000.000
ERC Starting...

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.

€ 1.499.980
ERC Advanced...

Healthy Microbiota Avoiding Fractures during Ageing

This project aims to identify gut microbiota signatures linked to age-related bone and muscle loss to develop novel fracture prevention therapies for the elderly.

€ 2.499.993
ERC Starting...

Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling

This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.

€ 1.499.323